Coqui RadioPharmaceuticals Completes Schematic Design for Medical Isotope Facility

Coqui RadioPharmaceuticals Corp. announced that it’s completed the schematic design for its $330-million medical isotope facility. It’s set to be built in Alachua, Florida.

As quoted in the press release:

The finalization of Coquí Pharma’s schematic design marks a significant milestone for the firm as they work toward becoming the first U.S. commercial supplier of the lifesaving radioisotope Molybdenum-99 (Mo-99), which is used in 20 million procedures each year in the U.S. Coquí Pharma will soon enter the detailed design phase as it readies to submit its construction license application to the Nuclear Regulatory Commission by the end of 2015.

Along with Argentinian nuclear engineering firm INVAP, Coquí Pharma also contracted multi-disciplinary architectural, engineering and environmental firm Gresham, Smith and Partners. Among the scope of work performed by Gresham, Smith and Partners is the design of the 250,000 square foot facility which is set to make a statement in supporting the global movement for environmentally sustainable design, construction and operational practice.

Carmen I. Bigles, president and CEO of Coqui, commented:

Our goal was to incorporate the most innovative design while sustaining the environment, and Gresham, Smith and Partners have created a remarkable vision for Coquí Pharma.

Click here to read the full Coqui RadioPharmaceuticals Corp. press release.